Experimental osteoporosis drug bests Lilly’s Forteo in study
The experimental medicine, called romosozumab, showed better results than Eli Lilly and Co.’s Forteo after 12 months, Amgen and UCB said in a joint statement Wednesday.
Health Care
Articles
Longtime IU Health leader Evans to retire next year
Daniel Evans Jr. plans to leave his post as president immediately and retire as CEO on May 1. The system’s chief operating officer, Dennis Murphy, will take over as president now and as CEO in the spring.
Novo Nordisk buying 2 DiMarchi-launched drug firms
Calibrium LLC and MB2 LLC, both based in Carmel, have agreed to be sold for undisclosed amounts. They were developing diabetes drugs discovered by the research team of Richard DiMarchi, a chemistry professor at Indiana University.
Lilly wins patent ruling over blockbuster drug Alimta
Eli Lilly and Co. won a court ruling that will keep generic versions of the chemotherapy drug Alimta off the U.S. market until a patent expires in 2022.
YMCA partners with VA for Pike Township center
Although the $10 million Pike Township YMCA has no timetable for completion, officials have pledged to offer extensive services to veterans in conjunction with the Richard L. Roudebush VA Medical Center.
IU School of Dentistry gets OK for $21.6M expansion
The IU Board of Trustees gave unanimous approval to the 45,000-square-foot addition to the school at IUPUI. It is expected to open in 2020.
Regenstrief CEO Tierney to depart for Texas job
Dr. Bill Tierney, who has led the Regenstrief medical informatics research operation for five years, will become chair of the department of population health at the Dell Medical School at the University of Texas at Austin.
Lilly shares jump after positive study of diabetes drug
Lilly’s stock had its biggest intraday gain since 2009 Thursday after it announced trial results that showed Jardiance lowered the risk of heart attacks, stroke and death in a large trial of adults with type 2 diabetes.
Anthem to cover libido pill; other insurers weighing decision
Concerns about serious side effects, including fainting, complicate discussions about whether to cover Sprout Pharmaceuticals' Addyi.
FDA approves female sex pill, but with safety restrictions
The Food and Drug Administration on Tuesday approved the first prescription drug designed to boost sexual desire in women, a milestone long sought by a pharmaceutical industry eager to replicate the blockbuster success of impotence drugs for men.
Indy medical device firm plans 125-job expansion
Catheter Research Inc.—which makes single-use medical devices, such as catheters—plans a $4.8 million expansion that will relocate its headquarters to larger space on the northwest side.
IU eyes clinical trials to boost research success
The new head of research at the Indiana University School of Medicine thinks the institution is missing out on the more than $6 billion spent each year in the United States on clinical trials.
Feds detail why they want Armstrong medical records
The federal government says it wants Lance Armstrong's medical records from his 1996 cancer treatments because they could prove just how far he was willing to go to conceal performance-enhancing drug use from the public and his sponsors.
Indianapolis doctor charged in overdose deaths of 3 patients
Dr. John Sturman overprescribed narcotics to patients at a clinic he operated at Indiana University Hospital, Marion County prosecutors contend. The deaths occurred in 2010 and 2011.
UPDATE: IU Health reaches labor settlement with nurses
Indiana University Health has agreed to revoke disciplinary actions against two nurses who tried to organize a union at IU Health’s Methodist Hospital earlier this year, the United Steelworkers announced.
Financial planning especially tricky for those with special-needs children
Many parents of children with special needs have to choose between working to help cover added expenses or unemployment so they can tend to their child full time. Financial planning is vital for these families, parents and special-needs advocates said.
UPDATE: Feds demand Armstrong medical records from IU
The government wants to see Lance Armstrong’s medical records from his treatments for cancer as it attempts to recover millions of dollars in sponsorship money paid to his cycling teams.
Lilly accused at trial of hiding Cymbalta ‘brain zap’ risk
The drugmaker faces as many as 5,000 cases claiming it downplayed Cymbalta’s withdrawal risks, which allegedly include electrical-shock sensations, vomiting and insomnia.
Indiana medical software company hack affected 3.9M people
The company said the exposed information includes names, addresses, birthdates, Social Security numbers and health records.
Tech firm to sponsor free rides for downtown bikeshare
Pedestrians in downtown Indy this weekend can become bicyclists for no charge, as a global technology firm sponsors free rides through the Indiana Pacers Bikeshare program.